Gómez-Labrador, C.; Ricart, E.; Iborra, M.; Iglesias, E.; Martín-Arranz, M.D.; de Castro, L.; De Francisco, R.; García-Alonso, F.J.; Sanahuja, A.; Gargallo-Puyuelo, C.J.;
et al. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA. Pharmaceutics 2024, 16, 629.
https://doi.org/10.3390/pharmaceutics16050629
AMA Style
Gómez-Labrador C, Ricart E, Iborra M, Iglesias E, Martín-Arranz MD, de Castro L, De Francisco R, García-Alonso FJ, Sanahuja A, Gargallo-Puyuelo CJ,
et al. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA. Pharmaceutics. 2024; 16(5):629.
https://doi.org/10.3390/pharmaceutics16050629
Chicago/Turabian Style
Gómez-Labrador, Celia, Elena Ricart, Marisa Iborra, Eva Iglesias, María Dolores Martín-Arranz, Luisa de Castro, Ruth De Francisco, Francisco Javier García-Alonso, Ana Sanahuja, Carla J. Gargallo-Puyuelo,
and et al. 2024. "Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA" Pharmaceutics 16, no. 5: 629.
https://doi.org/10.3390/pharmaceutics16050629
APA Style
Gómez-Labrador, C., Ricart, E., Iborra, M., Iglesias, E., Martín-Arranz, M. D., de Castro, L., De Francisco, R., García-Alonso, F. J., Sanahuja, A., Gargallo-Puyuelo, C. J., Mesonero, F., Casanova, M. J., Mañosa, M., Rivero, M., Calvo, M., Sierra-Ausin, M., González-Muñoza, C., Calvet, X., García-López, S.,
... Gisbert, J. P.
(2024). Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA. Pharmaceutics, 16(5), 629.
https://doi.org/10.3390/pharmaceutics16050629
